Free Newsletter
Medco buys Polymedica for $1.5B
Medco Health Solutions hopes that what's good for diabetes patients is also good for its bottom line. The company has agreed to pay $1.5 billion to acquire PolyMedica, the nation's largest supplier of blood-glucose testing supplies and other diabetes-related services.
The two companies already have been working together; Medco fills some 50,000 scrips a week for PolyMedica patients, and Polymedica has offered testing supplies and Medicare Part B management services to some Medco clients. The companies say the deal creates "the nation's most advanced large-scale practice focused on diabetes care."
Medco will pay $53 per share for PolyMedica, which closed Monday at $45.29. Together, the two companies will serve some 3.8 million diabetes patients.
- read the CNN report on the deal
Related Articles:
Diabetes epidemic triggers soaring drug market. Report
Medco reaches settlement with DOJ. Report
Medco to launch e-prescribing study with CMS. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: